New Boops Pets Calming Formula for Dogs Features KSM-66 Ashwagandha

The NASC-audited pet wellness brand partners with Ixoreal Biomed to include the clinically-studied adaptogenic ingredient in its new supplement.

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Ixoreal Biomed, the developer of KSM-66 Ashwagandha, announced that its clinically studied adaptogenic ingredient will be featured in a new Calming & Stress Relief supplement for dogs from NASC-audited pet wellness brand Boops Pets. The global calming supplements market is projected to reach $1.7 billion by 2032, up from $952.4 million in 2024, driven by growing demand for products to help manage fear and stress in dogs.

Why it matters

As an adaptogenic herb, KSM-66 Ashwagandha is proven to naturally support healthy cortisol levels and encourage calmer behavior in dogs, making it an ideal ingredient for pet calming supplements. Boops Pets' partnership with Ixoreal Biomed demonstrates the company's commitment to using scientifically-validated, high-quality ingredients in its pet wellness products.

The details

KSM-66 Ashwagandha is the safest and only clinically-studied ashwagandha on the market for pets, boasting 46 certifications for safety, efficacy, and manufacturing standards. Boops Pets selected this root-only extract after auditing multiple ashwagandha sources, citing its batch-to-batch consistency and validated clinical evidence specifically for dogs.

  • The global calming supplements market is projected to reach $1.7 billion by 2032, up from $952.4 million in 2024.

The players

Ixoreal Biomed

The developer of KSM-66 Ashwagandha, a division of the Baldwa Group with over 80 years of history.

Boops Pets

A science-first pet wellness company and NASC-audited brand that is launching a new Calming & Stress Relief supplement for dogs featuring KSM-66 Ashwagandha.

KSM-66 Ashwagandha

A clinically studied adaptogenic ingredient proven to reduce cortisol and support calmer behavior in dogs.

Got photos? Submit your photos here. ›

What they’re saying

“We've long known that ashwagandha can help humans manage stress, and research shows it can be equally effective for pets. We believe all animals can benefit from KSM-66 Ashwagandha's safe and natural calming powers, and we're thrilled to partner with Boops Pets, a company dedicated to quality, scientific rigor, and proven pet health supplements that support lifelong wellness.”

— Kartikeya Baldwa, CEO of Ixoreal Biomed (petsplusmag.com)

“We approach our supply chain with a zero-compromise policy on traceability and data. After auditing multiple ashwagandha sources, we found KSM-66 Ashwagandha was the only one that offered the batch-to-batch consistency and validated clinical evidence specifically for dogs.”

— Jeffrey Meng, Founder of Boops Pets (petsplusmag.com)

The takeaway

The partnership between Ixoreal Biomed and Boops Pets to include clinically-studied KSM-66 Ashwagandha in a new pet calming supplement demonstrates the growing demand for science-backed, high-quality ingredients in the booming pet wellness market.